MK
Mitchell Kapoor HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
146
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
76.5%
Neutral
11.8%
Negative
11.8%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $17 |
248%
upside
| 1 | +42% |
0
%
| 16 Mar ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $135 |
39%
upside
| 3 | -3.2% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $30 |
97%
upside
| 2 | +10% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $22 |
1%
upside
| 1 | -2.6% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Sell
Reiterated
| $5 |
77%
downside
| 3 | +10% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Neutral
Reiterated
| $55 |
0%
upside
| 3 | – |
–
| 2 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $30 |
19%
upside
| 2 | -1.3% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $45 |
31%
upside
| 1 | +48% |
0
%
| 17 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $65 |
132%
upside
| 2 | +26% |
0
%
| 10 Feb ‘26 2 months ago |
|
|
|
Buy
Upgraded
| $20 |
40%
upside
| 1 | +16% |
0
%
| 29 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $50 |
99%
upside
| 1 | -5.6% |
0
%
| 22 Jan ‘26 2 months ago |
|